Retention in HIV care predicts subsequent retention and predicts survival well after the first year of care: a national study of US Veterans

Similar documents
Karen Nieves-Lugo, PhD George Washington University

Community-Acquired Pneumonia More Frequent With HIV in Veterans Cohort

ORIGINAL INVESTIGATION. Cirrhosis and Hepatocellular Carcinoma in HIV-Infected Veterans With and Without the Hepatitis C Virus

Most persons who acquire hepatitis C virus

The University of Mississippi School of Pharmacy

Are Missed- and Kept-Visits-Based Measures Capturing Different Aspects of Retention in Care?

During the past 2 decades, an increase in the ageadjusted

Supplementary Material*

Determinants of Topical 5-Aminosalicylic Acid Use in Veterans with Ulcerative Colitis

Ethnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer. Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD,

HIV/AIDS CLINICAL CARE QUALITY MANAGEMENT CHART REVIEW CHARACTERISTICS OF PATIENTS FACTORS ASSOCIATED WITH IMPROVED IMMUNOLOGIC STATUS

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT

Survival Inequalities among Children, Adolescents and Young Adults with Acute Leukemia in California Renata Abrahão, MD MSc PhD

The relationship between adherence to clinic appointments and year-one mortality for HIV infected patients at a Referral Hospital in Western Kenya

Johns Hopkins University, 6 Health Resources and Services Administration, 7

Hepatitis C virus (HCV) is the most common

Mortality cohort study among problem drug users in Poland

Elements of the Care Continuum

Peter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang 1

Supplement for: CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time.

Abacavir is associated with increased risk of cardiovascular disease in HIV-infected patients: A UK clinic case-control study

Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications

Chronic Pain and Opioid Use in Women Veterans: Is there an Association with Menopause?

The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases

Identifying Geographic & Socioeconomic Disparities in Access to Care for Pediatric Cancer Patients in Texas

Linkage to care and initiating ART after diagnosis with acute or established HIV infection in 8 US emergency departments

A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY. Helen Mari Parsons

METHODS RESULTS. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC

The Contribution of Missed Clinic Visits to Disparities in HIV Viral Load Outcomes

GSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source

Treatment disparities for patients diagnosed with metastatic bladder cancer in California

DIABETES ASSOCIATED WITH ANTIPSYCHOTIC USE IN VETERANS WITH SCHIZOPHRENIA

IAS 2013 Towards an HIV Cure Symposium

Prevalence and correlates of obstructive sleep apnoea among patients with and without HIV infection

The Short-Term Incidence of Hepatocellular Carcinoma Is Not Increased After Hepatitis C Treatment with Direct-Acting Antivirals: An ERCHIVES Study

Liver Transplantation for Alcoholic Liver Disease in the United States: 1988 to 1995

Evaluating Retention in Medical Care and its Impact on the Health Outcomes of Individuals Living with Human Inmmunodeficiency Virus

Characterization of Patients with Poor-

Racial Differences in the Progression to Cirrhosis and Hepatocellular Carcinoma in HCV-Infected Veterans

Factors Associated with Initial Treatment for Clinically Localized Prostate Cancer

3rd IAS Conference on HIV Pathogenesis and Treatment. Poster Number Abstract #

Screening for hepatocellular carcinoma (HCC) is controversial.

Changes in viral suppression status among US HIV-infected patients receiving care

Epidemiology and Treatment of Colonic Angiodysplasia; a Population-Based Study. Naomi G. Diggs, MD Lisa L. Strate, MD MPH March 2, 2010

Menthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function

Journal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20.

A Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia

Factors associated with unsuppressed viral load in HIV-1 infected patients on 1 st line antiretroviral therapy in South Africa

Patterns of Care in Patients with Cervical Cancer:

Is exposure to Agent Orange a risk factor for hepatocellular cancer? A single-center retrospective study in the U.S. veteran population

Alexander Lankowski 1, Cedric Bien 1,2, Richard Silvera 1,2, Viraj Patel 1, Uriel Felsen 3, Oni Blackstock 1

Final Report 22 January 2014

We have no disclosures

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

Measure #340 (NQF 2079): HIV Medical Visit Frequency - National Quality Strategy Domain: Efficiency And Cost Reduction

Status of the CKD and ESRD treatment: Growth, Care, Disparities

COMBINING DATA SOURCES TO EVALUATE HIV HOUSING PROGRAMS: EXAMPLES

Comparing adherence items of missed doses with different timeframes and their associations with viral load in routine clinical care

Confounding in influenza VE studies in seniors, and possible solutions

The availability and cost are obstacles to using pvl in monitoring HIV treatment outcomes in resource-constrained settings

Page 1. diagnosed in the elderly it tends to hide increases in specific groups).

Case 4: A 61-year-old man with HCV genotype 3 with cirrhosis. Ira M. Jacobson, M.D. Weill Cornell Medical College New York, New York USA

A Competing Risk Analysis of Men Age Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer

Retention in Care: A Challenge to Survival with HIV Infection

Hepatitis B virus (HBV) and hepatitis C virus

Frailty Predicts Recurrent but Not Single Falls 10 Years Later in HIV+ and HIV- Women

Financial Incentives, Linkage to Care and Viral Suppression HPTN 065 (TLC-Plus) Study. Wafaa El-Sadr ICAP at Columbia University New York, NY

T he incidence of hepatocellular carcinoma (HCC) has

Country Focus of study (Objectives) Methods Participants Main findings. Longitudinal follow up study. analysis. study

DEPARTMENT OF HEALTH AND HUMAN SERVICES DIVISION OF PUBLIC HEALTH MANDY COHEN, MD, MPH SECRETARY

Renal Transplant Registry Report 2008

Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008

SECONDARY OBJECTIVES:

IMPACT OF AREA-POVERTY RATE ON LATE-STAGE COLORECTAL CANCER INCIDENCE IN INDIANA, NAACCR JUNE 22, 2017

Re-linkage and Retention in Care of HIV-diagnosed Persons presumed to be Out-of-Care Based on New York City Surveillance Data

Validation of Clinical Outcomes in Electronic Data Sources

Using claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center

Table 2.1. Cohort studies of ethylene oxide and lymphohaematopoeitic cancer

Arbolishvili GN, Mareev VY Institute of Clinical Cardiology, Moscow, Russia

Report Back from CROI 2010

Engagement in Outpatient Care for Patients Living with HIV (PLWH)

Viral hepatitis and Hepatocellular Carcinoma

HIV/AIDS Bureau Update

Geospatial Targeting of Young HIV-infected Men who have Sex with Men (YMSM) in CNICS

Professor Norbert Bräu

Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection

Decline of CD3-positive T-cell counts by 6 months of age is associated with rapid disease progression in HIV-1 infected infants

Who Decides? Self-selected versus Assigned Goals for Weight Loss in a Veteran Population

Natural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry

Finland and Sweden and UK GP-HOSP datasets

How hematologists perceive critical care- Acute myeloid leukemia

Predictors of Rehospitalization After Admission for Pneumonia in the Veterans Affairs Healthcare System

Department of Veterans Affairs

CANCER IN NSW ABORIGINAL PEOPLES. Incidence, mortality and survival September 2012

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.

Clinical Case. Prof.ssa Cristina Mussini

Determinants of Response to Pegylated Interferon and Ribavirin for Acute Hepatitis C Infection in Patients with Human Immunodeficiency Virus

Transcription:

Retention in HIV care predicts subsequent retention and predicts survival well after the first year of care: a national study of US Veterans Thomas P. Giordano, MD, MPH, Jessica A. Davila, PhD, Christine Hartman, PhD, Peter Richardson, PhD, Crystal Stafford, MPH, and Maria C. Rodriguez-Barradas, MD Houston Health Services Research and Development Center of Excellence, Michael E. DeBakey VA Medical Center, and the Department of Medicine, Baylor College of Medicine, Houston, TX, USA Abstract #137 Supported by VA HSR&D grant IBB 09-033 and the facilities and resources of the Michael E. DeBakey VA Medical Center, Houston. The views expressed in this poster are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.

None of the authors has any conflicts of interest related to the content of this presentation.

Background Retention in HIV care during the initial years of care impacts survival. 1,2 Whether subsequent retention continues to influence survival is unknown. The impact of prior poor retention on subsequent retention is also poorly described. The VA system is one of the largest single providers of HIV care in the US. 3 We sought to identify if poor retention predicted future poor retention and whether retention in later years of HIV care impacts survival. 1 Giordano, Clinical Infectious Diseases 2007; 44:1493 2 Mugavero et al. Clin Infect Dis 2009;48:248-56 3 Backus, Arch Intern Med 2010; 170:1239-1246.

Methods Design: Retrospective cohort study. Data source: Clinical Case Registry (CCR), a national VA database of all HIV-infected veterans who received care at all VA facilities; each case is locally validated as HIVpositive. 4 Time frame: Persons identified in VA with HIV between January 1998 and December 2008, with follow-up through December 2009. VA HIV date: The date of identification of HIV-positive status in the VA, using laboratory, pharmacy, and ICD-9 data. Retention in care: Number of 4-month blocks per year with 1 visit (0, 1, 2, or 3 of 3). Exposure Period: Retention in care, median VL, and median CD4 from the year prior to the year of interest. To ensure measurement of variables during the exposure period, persons who died during the exposure period were excluded. Analysis of Subsequent Retention in Care: Ordinal logistic regression (4-level outcome) for predictors of current retention in care, using retention in care in the previous year as a predictor. Retention over Time: Graphically demonstrated with a Kaplan-Meier analysis of time to first gap in care >180 days. Analysis of Survival: Cox proportional hazards regression models of death after Year 1 with Retention in Care measured as a time up-dated variable reflecting the proportion of four-month blocks during follow-up with a visit, lagged one year. 4 Backus, Arch Intern Med 2010; 170:1239-1246.

22,880 unique patients with first HIV date after 1/1/1998 Results 19,102 unique patients in analysis (83.5% of original cohort) Unreliable death dates (n=74) usage >90 d after death differing date of death by >90 d dead in CCR but not in Vital Status file Ineligible for follow-up (n=324) HIV diagnosis and death in same hospitalization died before first HIV date Uncertain about HIV status (n=405) only indication of HIV is single ICD-9 code No opportunity for follow-up (n=1384) first HIV date after 12/31/2008 HIV diagnosis in US Territory (n=325) Died before first year of follow-up completed ( n=1266) Figure 1: Defining the Cohort

Table 1: Baseline Characteristics % Sex Females 2.9 Males 97.1 Race Black 50.8 White 35.3 Hispanic 5.3 Other, unk. 8.7 Age <40 23.1 40-49 37.8 50+ 39.1 Mean (SD) 46.9 (10.4) CD4 cell count (first) 200 28.5 200-500 34.0 > 500 24.2 Missing 13.3 Mean (SD) 370 (290) HIV viral load (first) < 500 24.3 500-100k 40.1 > 100,000 18.4 Missing 17.3 Year of first HIV 1998-2000 31.1 2001-2008 68.9 Follow-up after first yr (yrs) 5.1 (3.1) %

Table 2: Retention in Care over Time Percent Retention in Care Baseline, Yr 1 (n=19,111) 3/3 blocks with appt 63.5 2/3 blocks with appt 17.7 1/3 blocks with appt 12.2 0/3 blocks with appt 6.6 Retention in Care, Yr 3 (n=15,120) 3/3 blocks with appt 56.3 2/3 blocks with appt 17.7 1/3 blocks with appt 10.2 0/3 blocks with appt 15.8 Retention in Care, Year 5 (n=11,409) 3/3 blocks with appt 56.3 2/3 blocks with appt 17.7 1/3 blocks with appt 9.1 0/3 blocks with appt 16.8 70 60 50 40 30 20 10 0 3 of 3 2 of 3 1 of 3 0 of 3 Year 1 Year 2 Year 3 Year 4 Year 5 Year 6

Proportion without Gap Time to First Gap in Care >180 days 1 0.9 1981 0.8 0.7 0.6 9185 0.5 5373 0.4 0.3 3138 1598 645 0.2 0.1 0 0 2 4 6 8 10 12 14 Time in years from first HIV date Mean follow-up 5.1 years (SD 3.1) after Year 1 3765 deaths in follow-up after Year 1

Year 1 to Year 2 7.8% 11.2% 45.2% 15.8% 18.2% 59.9% 21.0% 20.7% 1/3 0/3 17.5% 12.3% 6.9% 63.3% 2/3 3/3 16.0% 18.0% 27.4% 38.6% 3/3 Blocks 2/3 Blocks 5.7% 3.0% 15.7% 75.5% 1/3 Blocks 0/3 Blocks

28.1% 24.7% Year 3 to Year 4 6.0% 8.6% 13.1% 23.6% 23.5% 1/3 0/3 72.3% 10.1% 15.9% 17.5% 56.4% 2/3 3/3 14.6% 9.9% 29.1% 46.4% 3/3 Blocks 2/3 Blocks 1/3 Blocks 15.1% 4.2% 1.5% 79.2% 0/3 Blocks

22.9% Year 5 to Year 6 29.5% 4.9% 8.4% 12.5% 20.2% 27.4% 74.2% 1/3 0/3 17.4% 8.9% 17.0% 2/3 56.7% 3/3 14.0% 7.7% 48.0% 3/3 Blocks 4.2% 1.3% 14.3% 30.4% 2/3 Blocks 1/3 Blocks 80.2% 0/3 Blocks

Table 3: Previous Retention Predicts Subsequent Retention Predicting Better Retention in Care in Years 2, 4, and 6 Adjusted Odds Ratio (95% CI) P-value Year 2 Model 3/3 blocks with appt in Year 1 20.5 (18.2, 23.1) <0.0001 2/3 blocks with appt in Year 1 6.69 (5.93, 7.56) <0.0001 1/3 blocks with appt in Year 1 2.33 (2.06, 2.63) <0.0001 0/3 blocks with appt in Year 1 Referent Year 4 Model 3/3 blocks with appt in Year 3 43.0 (38.0, 48.6) <0.0001 2/3 blocks with appt in Year 3 15.8 (14.0, 17.9) <0.0001 1/3 blocks with appt in Year 3 6.57 (5.78, 7.46) <0.0001 0/3 blocks with appt in Year 3 Referent Year 6 model 3/3 blocks with appt in Year 5 42.7 (37.0, 49.3) <0.0001 2/3 blocks with appt in Year 5 16.8 (14.5, 19.4) <0.0001 1/3 blocks with appt in Year 5 8.41 (7.23, 9.80) <0.0001 0/3 blocks with appt in Year 5 Referent 0.96 (0.85, 1.09) All models adjusted for sex, race, age, era, baseline CD4, baseline VL, previous year s CD4, and previous year s VL.

Table 4: Cumulative Retention Predicts Mortality Predicting Mortality Adjusted Hazard Ratio (95% CI) P-value Retention in Care (Time-updated, cumulative percent of 4-month intervals with at least one visit, lagged one year) 81-100% Referent 61-80% 1.43 (1.30, 1.56) <0.0001 41-60% 1.64 (1.47, 1.83) <0.0001 21-40% 1.83 (1.64, 2.04) <0.0001 0-20% 1.55 (1.39, 1.72) <0.0001 Model adjusted for sex, race, age, era, baseline CD4, and baseline VL.

Discussion Retention in care drops quickly in the first 2 years of care, then drifts down more slowly. Prior retention in care strongly predicts future retention in care. Some persons with excellent retention in care appear to sustain that, but 25% are at risk for a decrease in status. Some persons with very poor retention in care appear to improve that, but most do not. With a mean of over 5 years follow-up, cumulative retention in care during follow-up continues to predict survival, even after adjusting for baseline CD4 cell count and VL. Limitations: Cannot account for care outside the VA system (though all deaths are captured).

Conclusions Prior retention in care strongly predicts future retention in care. Retention in care during all phases of HIV care, not just the initial years, predicts survival. Supported by VA HSR&D grant IBB 09-033 and the facilities and resources of the Michael E. DeBakey VA Medical Center, Houston. The views expressed in this poster are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.